glutathione oxidation Pathways oxidized is the oxidised dimeric form of glutathione that takes part in the body′s detoxification mechanisms The role of glutathione reductase
Description
MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss

Stay on course with real-time medical support STEP 3 Receive round-the-clock support and scheduled follow-ups to help you stay on track

High-resolution MS capability : Sub-ppm mass accuracy and deep proteome coverage enabled by Orbitrap Fusion Lumos and Q Exactive HF platforms Optimized enrichment workflow : GSH-targeted capture strategy enhances signal-to-noise ratio and recovers low-abundance S-glutathionylation sites Multi-PTM analysis compatibility : Supports co-enrichment and analysis with phosphorylation, ubiquitination, and nitrosylation for PTM crosstalk mapping End-to-end project adaptability : Flexible options for sample preparation, experimental design, and data reporting tailored to research needs Broad sample compatibility : Applicable to cell lysates, tissues, plasma/serum, and purified proteins across various biological systems Applications Our S-Glutathionylation Proteomics Service supports multiple research and preclinical use cases: Redox and stress signaling: Characterize dynamic redox-sensitive cysteine modifications under oxidative challenge Disease mechanism exploration: Construct SSG modification maps in models of cardiovascular, oncological, or neurodegenerative diseases Drug response and antioxidant evaluation: Track SSG shifts in response to GSH modulators, redox-targeted therapies, or dietary interventions Environmental toxicology: Study S-glutathionylation changes in response to pollutants, radiation, or chemical exposures Biomarker discovery: Identify site-specific SSG events with diagnostic or therapeutic potential Case Study Case 1: Mapping S-glutathionylation on Cardiac Myosin via Top-Down Proteomics In a study, researchers applied top-down mass spectrometry to map endogenous S-glutathionylation (SSG) on ventricular myosin light chain-1 (MLC-1v)

In addition to systemic adverse effects, inhibiting BCL-2 family members could be problematic for diseases and conditions of the CNS

This leads to increased muscle growth , density, and strength
